Farrelly Lorna A, Zheng Shuangping, Schrode Nadine, Topol Aaron, Bhanu Natarajan V, Bastle Ryan M, Ramakrishnan Aarthi, Chan Jennifer C, Cetin Bulent, Flaherty Erin, Shen Li, Gleason Kelly, Tamminga Carol A, Garcia Benjamin A, Li Haitao, Brennand Kristen J, Maze Ian
Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Beijing Advanced Innovation Center for Structural Biology, MOE Key Laboratory of Protein Sciences, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, 100084, Beijing, China.
Nat Commun. 2022 Apr 22;13(1):2195. doi: 10.1038/s41467-022-29922-0.
Schizophrenia (SZ) is a psychiatric disorder with complex genetic risk dictated by interactions between hundreds of risk variants. Epigenetic factors, such as histone posttranslational modifications (PTMs), have been shown to play critical roles in many neurodevelopmental processes, and when perturbed may also contribute to the precipitation of disease. Here, we apply an unbiased proteomics approach to evaluate combinatorial histone PTMs in human induced pluripotent stem cell (hiPSC)-derived forebrain neurons from individuals with SZ. We observe hyperacetylation of H2A.Z and H4 in neurons derived from SZ cases, results that were confirmed in postmortem human brain. We demonstrate that the bromodomain and extraterminal (BET) protein, BRD4, is a bona fide 'reader' of H2A.Z acetylation, and further provide evidence that BET family protein inhibition ameliorates transcriptional abnormalities in patient-derived neurons. Thus, treatments aimed at alleviating BET protein interactions with hyperacetylated histones may aid in the prevention or treatment of SZ.
精神分裂症(SZ)是一种由数百个风险变异之间的相互作用所决定的具有复杂遗传风险的精神疾病。表观遗传因素,如组蛋白翻译后修饰(PTMs),已被证明在许多神经发育过程中起关键作用,并且当受到干扰时也可能导致疾病的发生。在这里,我们应用一种无偏向的蛋白质组学方法来评估来自SZ患者的人诱导多能干细胞(hiPSC)衍生的前脑神经元中的组合组蛋白PTMs。我们观察到来自SZ病例的神经元中H2A.Z和H4的超乙酰化,这一结果在死后人类大脑中得到了证实。我们证明,含溴结构域和额外末端(BET)蛋白BRD4是H2A.Z乙酰化的真正“读取器”,并进一步提供证据表明抑制BET家族蛋白可改善患者来源神经元中的转录异常。因此,旨在减轻BET蛋白与超乙酰化组蛋白相互作用的治疗方法可能有助于预防或治疗SZ。